Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

A new state report shows that overdoses fell five percent in 2022, for the first time since 2018. State officials tout expanded access to harm reduction and treatment resources as a reason behind the trend.

Though deaths and hospitalizations for COVID-19 infections have stabilized, the Centers for Disease Control says as many as 4 million Americans are living with Long COVID.